6JEFFREY W, DELANEY M D, JENNIFER S, et al. Major complications associated with transcatheter atrial septal occluder implantation: A review of the medical literature and the Manufacturer and User Facility device Experience (MAUDE) Database[J]. Congenit Heart Dis, 2007,2 : 256-- 264.
7RODE'S-CABAUA J, PALACIOSB A, PALACIOB C, et al. Assessment of the markers of platelet and coagulation activation following transcatheter closure of atrial septal defects[J]. Int Cardiol, 2005, 98:107 --112.
8LOCK J E, ROME J J, DAVIS R, et al. Transcatheter closure of atrial septal defects- experimental studies[J]. Circulation, 1989,79 : 1091 - 1099.
9SHARAFUDDIN M J A, GU X, TITUS J L, et al. Transvenous closure of secundum atrial septal defects. Preliminary results with a new self-expanding nitinol prosthesis in a swine model[J]. Circulation,1997, 95: 2162--2168.
10CENNI E, CIAPETTI G, CERVELLATI M, et al. Activation of the plasma coagulation system induced by some biomaterials[J]. J Biomed Mater Res,1996, 31:145 --148.
